Positives

• A long COVID patient hoping for cognitive recovery may find rationale in animal data showing intranasal Semax raises BDNF expression in the hippocampus within 30 minutes of dosing Alzheimer's Drug Discovery Foundation.
  
  
• Users on a brain-health forum reported modest but consistent improvements in focus, learning, and mental fatigue, with effects felt 15 to 30 minutes after dosing LongeCity.
  
  

Negatives

• A LongeCity user found Semax too stimulating, comparing it to a methylphenidate-like crash a few hours after dosing LongeCity.
  
  
• A patient seeking rigorous evidence will find that human data are mostly from Russian post-stroke and pediatric trials, with no Western RCTs in long COVID Alzheimer's Drug Discovery Foundation.
  
  

Hurdles & Side Effects

• A US patient cannot obtain Semax through a regulated pharmacy and must source it from overseas or research-chemical vendors with variable quality Alzheimer's Drug Discovery Foundation.
  
  
• A patient who tries it must titrate carefully because some users find the energizing effect overlaps poorly with PEM and crash physiology LongeCity.